View in EDS HTML Full Text PDF Full Text

Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma.

Saved in:
Bibliographic Details
Title: Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma.
Authors: Zhao, Junjie1 (AUTHOR), Tang, Yanfeng1 (AUTHOR), Hu, Xu1 (AUTHOR), Yin, Xiaoxue2 (AUTHOR), Chen, Yuntian3 (AUTHOR), Chen, Junru1 (AUTHOR), Liu, Haoyang1 (AUTHOR), Liu, Haolin1 (AUTHOR), Liang, Jiayu1 (AUTHOR), Zhang, Xingming1 (AUTHOR), Zhao, Jinge1 (AUTHOR), Zhu, Sha1 (AUTHOR), Ni, Yuchao1 (AUTHOR), Wang, Zhipeng1 (AUTHOR), Dai, Jindong1 (AUTHOR), Wang, Zilin1 (AUTHOR), Zhang, Yaowen1 (AUTHOR), Yao, Jin3 (AUTHOR), Chen, Ni2 (AUTHOR), Shen, Pengfei1 (AUTHOR)
Source: Molecular Cancer. 6/26/2024, Vol. 23 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-024-02044-5